BIOTRONIK today announced the publication of the COMPAS clinical trial results in the European Heart Journal 1. COMPAS is the first large-scale, prospective, multi-center, randomized clinical trial to ...
December 8, 2011 (Rennes, France) — Remote monitoring of patients with dual-chamber pacemakers "was a safe substitute for conventional follow-ups, decreased the number of [clinic] visits, and enabled ...
WASHINGTON -- The government has approved a pacemaker outfitted with a tiny transmitter that can tell your doctor how your heart is doing -- the first medical implant capable of such real-time ...
FDA has approved its single- and dual-chamber Entovis pacemakers for use in MRI environments, according to Biotronik Inc. The Lake Oswego, OR-based US subsidiary of Biotronik SE & Co. KG (Berlin) said ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results